Director Dino News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director dino. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Dino Today - Breaking & Trending Today

Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $145.00

Krystal Biotech (NASDAQ:KRYS – Get Rating) had its price objective lifted by Stifel Nicolaus from $102.00 to $145.00 in a research report released on Wednesday morning, The Fly reports. Several other research analysts have also recently commented on KRYS. William Blair restated an outperform rating on shares of Krystal Biotech in a research report on […] ....

United States , William Blair , Daniel Janney , Dinoa Rossi , Stifel Nicolaus , Proshare Advisors , Group Plc , Krystal Biotech Inc , Manufacturers Life Insurance Company , Allspring Global Investments Holdings , Goldman Sachs Group , Krystal Biotech , Get Rating , Director Daniel Janney , Director Dino , Global Investments Holdings , State Retirement System , General Group Plc , Share Advisors , Krystal Biotech Daily , Nasdaq Krys , Boost Price Target ,

StockNews.com Upgrades Fortuna Silver Mines (NYSE:FSM) to Hold

Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) – Equities research analysts at HC Wainwright raised their Q3 2023 earnings per share (EPS) estimates for Krystal Biotech in a research note issued to investors on Monday, May 22nd. HC Wainwright analyst J. Pantginis now expects that the company will post earnings of ($1.02) per share for […] ....

United States , Daniel Janney , Stifel Nicolaus , Dinoa Rossi , William Blair , Krystal Biotech Inc , Krystal Biotech Company Profile , Victory Capital Management Inc , Avoro Capital Advisors , Dimensional Fund Advisors , Krystal Biotech , Get Rating , Biotech Trading Down , Director Dino , Director Daniel Janney , Street Corp , Capital Advisors , Capital Management , Fund Advisors , Krystal Biotech Daily , Nasdaq Krys , Earnings Estimates , Hc Wainwright ,

Krystal Biotech (NASDAQ:KRYS) PT Raised to $145.00

Krystal Biotech (NASDAQ:KRYS – Get Rating) had its price target raised by equities research analysts at Stifel Nicolaus from $102.00 to $145.00 in a report issued on Wednesday, The Fly reports. Stifel Nicolaus’ price objective suggests a potential upside of 23.52% from the stock’s current price. Other equities analysts have also recently issued reports about […] ....

United States , William Blair , Dinoa Rossi , Stifel Nicolaus , Daniel Janney , Stifel Nicolau , Almanack Investment Partners , Tower Research Capital , Cubist Systematic Strategies , Great West Life Assurance Co , Securities Exchange Commission , Allspring Global Investments Holdings , Krystal Biotech Inc , Krystal Biotech , Get Rating , Director Dino , Exchange Commission , Director Daniel Janney , Investment Partners , Global Investments Holdings , West Life Assurance , Research Capital , Krystal Biotech Daily , Nasdaq Krys , Boost Price Target ,

Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $148.00 at Chardan Capital

Krystal Biotech (NASDAQ:KRYS – Get Rating) had its target price upped by Chardan Capital from $133.00 to $148.00 in a research note issued to investors on Monday morning, The Fly reports. Other equities analysts have also recently issued research reports about the stock. William Blair reaffirmed an outperform rating on shares of Krystal Biotech in […] ....

United States , Stifel Nicolaus , Daniel Janney , William Blair , Dinoa Rossi , Great West Life Assurance Co , Tower Research Capital , Almanack Investment Partners , Goldman Sachs Group , Krystal Biotech Inc , Allspring Global Investments Holdings , Cubist Systematic Strategies , Krystal Biotech , Get Rating , Chardan Capital , Biotech Stock Down , Director Daniel Janney , Director Dino , Investment Partners , Global Investments Holdings , West Life Assurance , Research Capital , Krystal Biotech Daily , Nasdaq Krys , Boost Price Target ,